179 related articles for article (PubMed ID: 25592983)
1. Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-γ receptor deficiency.
Tesi B; Sieni E; Neves C; Romano F; Cetica V; Cordeiro AI; Chiang S; Schlums H; Galli L; Avenali S; Tondo A; Canessa C; Henter JI; Nordenskjöld M; Hsu AP; Holland SM; Neves JF; Azzari C; Bryceson YT
J Allergy Clin Immunol; 2015 Jun; 135(6):1638-41. PubMed ID: 25592983
[No Abstract] [Full Text] [Related]
2. Diagnostic difficulties of the hemophagocytic lymphohistiocytosis (HLH) associated with the Epstein-Barr virus.
Gonzalo DH; Rodriguez G; Marcilla D
J Pediatr Hematol Oncol; 2007 Mar; 29(3):206-7. PubMed ID: 17356405
[No Abstract] [Full Text] [Related]
3. Etiologies and Clinical Outcomes of Patients With Secondary Hemophagocytic Lymphohistiocytosis at a Tertiary PICU.
Dao D; Xoay TD; Galeano BK; Phuc PH; Ouellette Y
Pediatr Crit Care Med; 2019 Jul; 20(7):e311-e318. PubMed ID: 31149968
[TBL] [Abstract][Full Text] [Related]
4. Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.
Nawathe PA; Ravindranath TM; Satwani P; Baird JS
Pediatr Crit Care Med; 2013 May; 14(4):e176-81. PubMed ID: 23439459
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
[TBL] [Abstract][Full Text] [Related]
6. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S;
Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711
[TBL] [Abstract][Full Text] [Related]
7. Fatal Epstein-Barr virus infection in a case of familial hemophagocytic lymphohistiocytosis with syntaxin-11 mutation.
Albayrak M; Kaya Z; Yilmaz-Keskin E; Stadt UZ; Koçak U; Gürsel T
Turk J Pediatr; 2009; 51(4):371-4. PubMed ID: 19950846
[TBL] [Abstract][Full Text] [Related]
8. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
9. Infection of T lymphocytes in non-Asian patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Imashuku S
Pediatr Blood Cancer; 2009 Dec; 53(7):1359; author reply 1360. PubMed ID: 19533652
[No Abstract] [Full Text] [Related]
10. Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis.
Ito Y; Kawamura Y; Iwata S; Kawada J; Yoshikawa T; Kimura H
Pediatr Blood Cancer; 2013 Feb; 60(2):326-8. PubMed ID: 22961815
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile in fatal human immunodeficiency virus tuberculosis Epstein-Barr virus associated hemophagocytic syndrome.
Wong CK; Wong BC; Chan KC; Joynt GM; Yap FY; Lam CW; Lee N; Lee SS; Cockram CS; Sung JJ; Chan PK; Lo YM; Tang JW
Arch Intern Med; 2007 Sep; 167(17):1901-3. PubMed ID: 17893313
[No Abstract] [Full Text] [Related]
12. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
Parvaneh N; Filipovich AH; Borkhardt A
Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
[TBL] [Abstract][Full Text] [Related]
13. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies.
McClain K; Gehrz R; Grierson H; Purtilo D; Filipovich A
Am J Pediatr Hematol Oncol; 1988; 10(3):196-205. PubMed ID: 2845831
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.
Fox CP; Shannon-Lowe C; Gothard P; Kishore B; Neilson J; O'Connor N; Rowe M
Clin Infect Dis; 2010 Jul; 51(1):66-9. PubMed ID: 20504238
[TBL] [Abstract][Full Text] [Related]
15. Disseminated hyperkeratotic and granulomatous nodules in a child with fatal Epstein-Barr-virus-associated hemophagocytic lymphohistiocytosis.
Brinkmeier T; Reuter T; Metze D; Frosch PJ; Herbst RA
Pediatr Dermatol; 2006; 23(1):35-8. PubMed ID: 16445409
[TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype and functional analysis of a rare XIAP/BIRC4 mutation.
Vieth S; Ammann S; Schwarz K; Härtel C; Schultz C; Lehmberg K; Lauten M
Klin Padiatr; 2013 Nov; 225(6):343-6. PubMed ID: 24166087
[TBL] [Abstract][Full Text] [Related]
17. Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients.
Sonke GS; Ludwig I; van Oosten H; Baars JW; Meijer E; Kater AP; de Jong D
Clin Infect Dis; 2008 Jul; 47(1):105-8. PubMed ID: 18491961
[TBL] [Abstract][Full Text] [Related]
18. Not all cytokin storms are due to COVID-19: Hemophagotic syndrome with renal involvement secondary to extranasal lymphoma and Epstein-Barr virus. A case report during the pandemic.
Santana Quintana A; Valga F; Vega Díaz N; Fernández JM; Quevedo Reina JC; Rincón Tirado M; Aladro Escribano S; Rodríguez Pérez JC
Nefrologia (Engl Ed); 2021; 41(3):347-349. PubMed ID: 33069494
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus-associated haemophagocytic lympho-histiocytosis after stem cell transplantation.
Boelens JJ; Lazo G; Gaiser JF; Wulffraat NM
Bone Marrow Transplant; 2006 Nov; 38(10):709-10. PubMed ID: 17013422
[No Abstract] [Full Text] [Related]
20. Hematopoietic Stem Cell Transplantation in a Patient With ICF2 Syndrome Presenting With EBV-Induced Hemophagocytic Lymphohystiocytosis.
Harnisch E; Buddingh EP; Thijssen PE; Brooks AS; Driessen GJ; Kersseboom R; Lankester AC
Transplantation; 2016 Jul; 100(7):e35-6. PubMed ID: 27326813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
